Wollenberg A, de Bruin-Weller M, Thyssen JP, Beck LA, Simpson EL, Imafuku S, Boguniewicz M, Kurbasic A, Soldbro L, Strange Vest N, Arlert P, Paller AS. Conjunctivitis in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial. J of Skin [Internet]. 2022 Nov. 16 [cited 2024 Jul. 23];6(6):s75. Available from: https://jofskin.org/33014/index.php/skin/article/view/1832